Parenteral application of NADH in Parkinson's disease: clinical improvement partially due to stimulation of endogenous levodopa biosynthesis. (Q53993678)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Parenteral application of NADH in Parkinson's disease: clinical improvement partially due to stimulation of endogenous levodopa biosynthesis.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

23 May 2018

http://europepmc.org/abstract/MED/9013405

Parenteral application of NADH in Parkinson's disease: clinical improvement partially due to stimulation of endogenous levodopa biosynthesis. (English)

1 reference

Europe PubMed Central

PubMed publication ID

23 May 2018

http://europepmc.org/abstract/MED/9013405

Parkinson's disease

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

W Kuhn

1

1 reference

Europe PubMed Central

PubMed publication ID

23 May 2018

http://europepmc.org/abstract/MED/9013405

T Müller

2

1 reference

Europe PubMed Central

PubMed publication ID

23 May 2018

http://europepmc.org/abstract/MED/9013405

R Winkel

3

1 reference

Europe PubMed Central

PubMed publication ID

23 May 2018

http://europepmc.org/abstract/MED/9013405

S Danielczik

4

1 reference

Europe PubMed Central

PubMed publication ID

23 May 2018

http://europepmc.org/abstract/MED/9013405

A Gerstner

5

1 reference

Europe PubMed Central

PubMed publication ID

23 May 2018

http://europepmc.org/abstract/MED/9013405

R Häcker

6

1 reference

Europe PubMed Central

PubMed publication ID

23 May 2018

http://europepmc.org/abstract/MED/9013405

C Mattern

7

1 reference

Europe PubMed Central

PubMed publication ID

23 May 2018

http://europepmc.org/abstract/MED/9013405

H Przuntek

8

1 reference

Europe PubMed Central

PubMed publication ID

23 May 2018

http://europepmc.org/abstract/MED/9013405

publication date

1 January 1996

1 reference

Europe PubMed Central

PubMed publication ID

23 May 2018

http://europepmc.org/abstract/MED/9013405

Journal of Neural Transmission

1 reference

Europe PubMed Central

PubMed publication ID

23 May 2018

http://europepmc.org/abstract/MED/9013405

103

1 reference

Europe PubMed Central

PubMed publication ID

23 May 2018

http://europepmc.org/abstract/MED/9013405

10

1 reference

Europe PubMed Central

PubMed publication ID

23 May 2018

http://europepmc.org/abstract/MED/9013405

1187-1193

1 reference

Europe PubMed Central

PubMed publication ID

23 May 2018

http://europepmc.org/abstract/MED/9013405

Stimulation of dopamine biosynthesis in cultured PC 12 phaeochromocytoma cells by the coenzyme nicotinamide adeninedinucleotide (NADH)

1 reference

https://pubmed.ncbi.nlm.nih.gov/9013405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Biosynthesis and metabolism of tetrahydrobiopterin and molybdopterin

1 reference

https://pubmed.ncbi.nlm.nih.gov/9013405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pathogenesis of idiopathic parkinsonism

1 reference

https://pubmed.ncbi.nlm.nih.gov/9013405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The coenzyme nicotinamide adenine dinucleotide (NADH) improves the disability of parkinsonian patients.

1 reference

https://pubmed.ncbi.nlm.nih.gov/9013405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intestinal absorption of tetrahydrobiopterin and biopterin in man

1 reference

https://pubmed.ncbi.nlm.nih.gov/9013405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of Parkinson's disease with NADH

1 reference

https://pubmed.ncbi.nlm.nih.gov/9013405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nicotinamide adenine dinucleotide (NADH)--a new therapeutic approach to Parkinson's disease. Comparison of oral and parenteral application

1 reference

https://pubmed.ncbi.nlm.nih.gov/9013405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tyrosine hydroxylase activity in caudate nucleus from Parkinson's disease: effects of iron and phosphorylating agents.

1 reference

https://pubmed.ncbi.nlm.nih.gov/9013405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The clinical benefit of NADH as stimulator of endogenous L-dopa biosynthesis in parkinsonian patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/9013405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Stimulation of retinal dopamine biosynthesis in vivo by exogenous tetrahydrobiopterin: relationship to tyrosine hydroxylase activation

1 reference

https://pubmed.ncbi.nlm.nih.gov/9013405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Stimulation of endogenous L-dopa biosynthesis--a new principle for the therapy of Parkinson's disease. The clinical effect of nicotinamide adenine dinucleotide (NADH) and nicotinamide adenine dinucleotidephosphate (NADPH).

1 reference

https://pubmed.ncbi.nlm.nih.gov/9013405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF01271203

1 reference

Europe PubMed Central

PubMed publication ID

23 May 2018

http://europepmc.org/abstract/MED/9013405

release_pxsokbqjjbcjndhjycbp6twlei

1 reference

https://api.fatcat.wiki/v0/release/pxsokbqjjbcjndhjycbp6twlei

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

23 May 2018

http://europepmc.org/abstract/MED/9013405

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53993678&oldid=2212340622"